Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02456077 · ClinicalTrials.gov registry record · NA
Strengthening Physician Communication About HPV Vaccines
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 93,582
- Enrollment target
NCT02456077: Completed NA study, sponsored by University of Colorado, Denver.
NCT02456077 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 93,582 participants, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (6575% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02456077, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 93,582 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a multimodal Human Papillomavirus (HPV) immunization program carried out in pediatric and family medicine practices would be more effective in improving adolescent patients' HPV immunization rates than the usual care provided to adolescents in pediatric and family medicine practices.
Primary Outcome
The percent of eligible patients presenting for care at intervention offices who receive one or more HPV vaccines (using administrative, Electronic Medical Records (EMR), and Colorado Immunization Information System (CIIS) immunization data), during the intervention year, compared to the percent in control offices.
Interventions
- BEHAVIORAL Multimodal Vaccine Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93,582 participants |
| Start Date | 2015-02-01 |
| Est. Completion | 2016-01-31 |
| Phase | NA |
What the finished NCT02456077 record still lists
NCT02456077 is an interventional study that assigns participants to a tested intervention. Its 93,582 participants enrollment target places it among the larger protocols in the corpus, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (6575% higher).
The record links to 0 conditions, and to 1 intervention - of which Multimodal Vaccine Program is the first listed.
NCT02456077 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02456077 about?
NCT02456077 is a clinical study titled "Strengthening Physician Communication About HPV Vaccines". The purpose of this study is to determine if a multimodal Human Papillomavirus (HPV) immunization program carried out in pediatric and family medicine practices would be more effective in improving adolescent patients' HPV immunization rates than the usual care provided to adolescents in pediatric a...
What is the current status of trial NCT02456077?
This trial is currently completed. It is a NA study. The enrollment target is 93,582 participants. The study started on 2015-02-01. Estimated completion is 2016-01-31.
What interventions are being tested in trial NCT02456077?
The interventions under investigation include: Multimodal Vaccine Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02456077?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02456077's enrollment target sits among peer trials
93,582 3rd of 2000 higher than 1,998 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01351545 · 99,999 participants
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- NCT02620852 · 100,000 participants · NA
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- NCT03277365 · 100,000 participants · NA
MyGeneRank: A Digital Platform for Next-Generation Genetic Studies
- NCT04281823 · 100,000 participants
DeBakey Cardiovascular Magnetic Resonance Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI